IRIS Accounts Production v25.4.0.155 09518432 Board of Directors 1.4.24 31.3.25 31.3.25 false true false false false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh095184322024-03-31095184322025-03-31095184322024-04-012025-03-31095184322023-03-31095184322023-04-012024-03-31095184322024-03-3109518432ns15:EnglandWales2024-04-012025-03-3109518432ns14:PoundSterling2024-04-012025-03-3109518432ns10:Director12024-04-012025-03-3109518432ns10:PrivateLimitedCompanyLtd2024-04-012025-03-3109518432ns10:Micro-entities2024-04-012025-03-3109518432ns10:AuditExempt-NoAccountantsReport2024-04-012025-03-3109518432ns10:SmallCompaniesRegimeForAccounts2024-04-012025-03-3109518432ns10:FullAccounts2024-04-012025-03-3109518432ns5:CurrentFinancialInstruments2025-03-3109518432ns5:CurrentFinancialInstruments2024-03-3109518432ns10:RegisteredOffice2024-04-012025-03-31
REGISTERED NUMBER: 09518432 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2025

FOR

D.U.L LABORATORIES LIMITED

D.U.L LABORATORIES LIMITED (REGISTERED NUMBER: 09518432)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025




Page

Balance Sheet 1


D.U.L LABORATORIES LIMITED (REGISTERED NUMBER: 09518432)

BALANCE SHEET
31 MARCH 2025

31.3.25 31.3.24
£    £    £    £   
FIXED ASSETS 3,654 4,872

CURRENT ASSETS 29,112 14,803

CREDITORS
Amounts falling due within one year (347,521 ) (188,808 )
NET CURRENT LIABILITIES (318,409 ) (174,005 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

(314,755

)

(169,133

)

CAPITAL AND RESERVES (314,755 ) (169,133 )

NOTES TO THE FINANCIAL STATEMENTS

1. STATUTORY INFORMATION

D.U.L Laboratories Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 09518432

Registered office: Charlton House
Dour Street
Dover
Kent
CT16 1BL

The presentation currency of the financial statements is the Pound Sterling (£).


2. CHANGE OF DIRECTORS DURING THE YEAR

On 21 November 2024 Grzegorz Kubiak resigned as director and Derek and Miroslawa Ward were appointed as directors.

3. AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 5 (2024 - 1 ) .

4. OFF-BALANCE SHEET ARRANGEMENTS

At the year end the company had operating lease commitments totalling £22,273, with £8,311 being due within one year and £13,962 due in years two to five.

4. GOING CONCERN

The financial statements have been prepared on a going concern basis. This basis is considered appropriate, notwithstanding that the company has incurred losses during the year, as it continues to receive ongoing financial support from other trading companies under the ownership of the director Mr D Ward.



D.U.L LABORATORIES LIMITED (REGISTERED NUMBER: 09518432)

BALANCE SHEET - continued
31 MARCH 2025


The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 2 January 2026 and were signed on its behalf by:





D A Ward - Director